W-SUDs for COVID-19

Woebot Health

Status and phase: Completed; Phase 1

Conditions: Substance Use Disorders; Alcohol Use Disorder

Treatments: Other: Woebot Substance Use Disorder

Study type: Interventional

Funder types: Other; Industry; NIH

Identifiers

NCT04460027

4R44DA048712-02 (U.S. NIH Grant/Contract)

56439

Details and patient eligibility

About

The purpose of this study is to test the efficacy of a substance use disorder intervention delivered via a mobile application in an adult population during the COVID-19 pandemic.

This study that will test the comparative efficacy of the mobile-app based substance use disorder program to reduce substance use relative to a wait list control condition, and explore between group differences on quality of life indices as well as retention and engagement during COVID-19.

Enrollment: 180 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• All genders aged 18-65 years
• Access to a smartphone
• Available and committed to engage with app and complete assessments
• Be willing to provide email address (as this is how assessment incentives will be distributed),
• Literate in English (as W-SUDs conversational and video materials will be in English).

Exclusion criteria

• Pregnancy (as W-SUDs will not be specifically developed to address the unique needs of this population)
• History of severe drug/alcohol use
• History of opioid misuse without medication-assisted treatment
• Suicide attempt within the past year
• Opioid overdose within the past year

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

180 participants in 2 patient groups

W-SUDs

Experimental group

Treatment:

Other: Woebot Substance Use Disorder

Wait List Control

No Intervention group